As a company specializing in manufacturing non-sterile medications, food supplements and OTC products, contract manufacturing, clinical trials, and quality system consulting, Arafarma Group offers brand generics and innovative products. Their medications are notably sugar and glucose-free, catering to a niche market. Operating within the Urology, Gynecology, Dermatology, Traumatology, Rheumatology, and Cardiovascular fields, Arafarma Group delivers a full cycle of finished products manufactured according to GMP standards. Innovations aimed at generating added value for customers and patients are a cornerstone of the company's approach.
With its headquarters in Spain, Arafarma Group has shown promise in the manufacturing and pharmaceutical industries. Although the specific details regarding their latest investment, investors, or investment date remain undisclosed, Arafarma Group presents an intriguing investment opportunity within the pharmaceutical manufacturing sector, driven by its commitment to innovation and quality.